StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Thermo Fisher Scientific (TMO) PT Raised to $650 at Barclays
July 24, 2026 5:06 AM
Barclays analyst Luke Sergott raised the price target on Thermo Fisher Scientific (NYSE:
TMO
) to $650.00 (from $625.00) while maintaining a Overweight rating.
Categories
Analyst PT Change